AVIVA STRATEGIES (FKA MGB CONSULTING)

Lobbying for ELEMENT BIOSCIENCES · Biotechnology

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $39,000.00 income · posted Jan 15, 2026

Lobbying activity 2

Health Issues

- Regulatory streamlining - Genomic sequencing - National Biotechnology Initiative Act of 2025

Medical/Disease Research/Clinical Labs

- National Security Commission on Emerging Biotechnology

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.